SMN2 and proximal spinal muscular atrophy: Infants enrolled in NURTURE were ≤6 weeks of age at first dose and, based on SMN2 copy number and expected concordance of phenotype with an affected sibling(s), were predicted to have type I or II SMA (15 children with 2 SMN2 copies and 10 children with 3 SMN2 copies).